Myrtle S Potter Guardant Health, Inc. (GH) insider trading activity

GH Quotes by TradingView

Myrtle S Potter is Director of Guardant Health, Inc.. Currently has a direct ownership of 13,585 shares of GH, which is worth approximately $297,239. The most recent transaction as insider was on Oct 15, 2024, when has been sold 69 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.6K
1.53% 3M change
89.42% 12M change
Total Value Held $297,239

MYRTLE S POTTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2024
BUY
Exercise of conversion of derivative security
-
69 Added 0.51%
13,585 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.5%
13,516 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.5%
13,448 Common Stock
Jul 15 2024
BUY
Exercise of conversion of derivative security
-
69 Added 0.51%
13,380 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.51%
13,311 Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
5,592 Added 29.69%
13,243 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
69 Added 0.89%
7,651 Common Stock
Apr 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.89%
7,582 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.9%
7,514 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
69 Added 0.92%
7,446 Common Stock
Jan 15 2024
BUY
Exercise of conversion of derivative security
-
68 Added 0.91%
7,377 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
-
69 Added 0.94%
7,309 Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 0.93%
7,240 Common Stock
Oct 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 0.94%
7,172 Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
-
69 Added 0.96%
7,104 Common Stock
Aug 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 0.96%
7,035 Common Stock
Jul 15 2023
BUY
Exercise of conversion of derivative security
-
69 Added 0.98%
6,967 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 0.98%
6,898 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
-
5,531 Added 44.75%
6,830 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 4.97%
1,299 Restricted Stock Units
Apr 15 2023
BUY
Exercise of conversion of derivative security
-
69 Added 5.31%
1,231 Restricted Stock Units
Mar 15 2023
BUY
Grant, award, or other acquisition
-
68 Added 5.53%
1,162 Restricted Stock Units
Feb 15 2023
BUY
Grant, award, or other acquisition
-
69 Added 5.93%
1,094 Restricted Stock Units
Jan 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 6.22%
1,025 Restricted Stock Units
Dec 15 2022
BUY
Grant, award, or other acquisition
-
68 Added 6.63%
957 Restricted Stock Units

Also insider at

RAD
RITE AID CORP Healthcare
Director
UROV
Urovant Sciences Ltd.
Director
MYOV
Myovant Sciences Ltd. Healthcare
Director
DNA
Ginkgo Bioworks Holdings, Inc. Healthcare
Director
MSP

Myrtle S Potter

Director
Camp Hill, PA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GH